WASHINGTON, March 2 (Reuters) - The U.S. Food and Drug Administration on Friday said GlaxoSmithKline Plc's (GSK.L) (GSK.N) seizure drug Lamictal was not withdrawn from sale for safety or effectiveness reasons.
The FDA said the ruling paves the way for the agency to approve generic versions of the drug, also known as lamotrigine.
WASHINGTON (Reuters) - Last week's failed plot to bomb a U.S. passenger jet has exposed lingering fissures within the U.S. intelligence community, which had information from interviews and clandestine intercepts but did not put the pieces together, officials said.
Hong Kong is poised to accept Beijing's accounting standards. That's good. The system, though, is prone to scandal. That's bad. Full Article
Boycotting "too big to fail" banks is a great idea -- so long as investors remember that banks aren't the only ones responsible for the crisis. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
